Navigation Links
PolyOne Completes Acquisition of GLS Corporation
Date:1/3/2008

Acquisition advances specialization strategy

CLEVELAND, Jan. 2 /PRNewswire-FirstCall/ -- PolyOne Corporation (NYSE: POL), a leading global provider of specialized polymer materials, services and solutions, announced today it has completed its previously announced acquisition of GLS Corporation, the leading North American provider of specialty thermoplastic elastomer compounds (TPEs) for consumer and medical applications.

This acquisition complements PolyOne's global Engineered Materials business portfolio and accelerates the company's shift to specialization. The combination of GLS's specialty TPE technology, compounding expertise and brand, along with PolyOne's extensive global infrastructure and commercial presence offers customers enhanced technologies; a broader range of products, services and solutions; and expanded access to specialized, high-growth markets around the globe.

The experienced GLS senior management team will remain and lead the global TPE business unit, retaining the GLS name and brand.

GLS was formerly a family-owned business headquartered in McHenry, Illinois. It has built a superb reputation as a strategic partner to many of the world's best-known companies in developing and marketing highly customized soft TPEs. With approximately 200 employees, GLS has manufacturing facilities in Illinois and Suzhou, China. Annual sales are approximately $130 million.

About PolyOne

PolyOne Corporation, with 2006 annual revenues of $2.6 billion, is a leading global provider of specialized polymer materials, services and solutions. Headquartered in northeast Ohio, PolyOne has operations in North America, South America, Europe, Asia and Australia, and joint ventures in North America and South America. See http://www.polyone.com for additional information on PolyOne.

Forward-looking Statements

In this press release, statements that are not reported financial results or other historical information are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements give current expectations or forecasts of future events and are not guarantees of future performance. They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. You can identify these statements by the fact that they do not relate strictly to historic or current facts. They use words such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe," and other words and terms of similar meaning in connection with any discussion of future operating or financial performance and/or sales. In particular, these include statements relating to future actions; prospective changes in raw material costs, product pricing or product demand; future performance; results of current and anticipated market conditions and market strategies; sales efforts; expenses; the outcome of contingencies such as legal proceedings; and financial results including those of GLS. Factors that could cause actual results to differ materially include, but are not limited to:
- the effect on foreign operations of currency fluctuations, tariffs,

nationalization, exchange controls, limitations on foreign investment

in local businesses and other political, economic and regulatory risks;

- changes in polymer consumption growth rates within the U.S., Europe or

Asia or other countries where PolyOne conducts business;

- changes in global industry capacity or in the rate at which anticipated

changes in industry capacity come online in the polyvinyl chloride

(PVC), chlor-alkali, vinyl chloride monomer (VCM) or other industries

in which PolyOne participates;

- fluctuations in raw material prices, quality and supply and in energy

prices and supply, in particular fluctuations outside the normal range

of industry cycles;

- production outages or material costs associated with scheduled or

unscheduled maintenance programs;

- the cost of compliance with environmental laws and regulations,

including any increased cost of complying with new or revised laws and

regulations;

- unanticipated developments that could occur with respect to

contingencies such as litigation and environmental matters, including

any developments that would require any increase in our costs and/or

reserves for such contingencies;

- an inability to achieve or delays in achieving or achievement of less

than the anticipated financial benefit from initiatives related to cost

reductions and employee productivity goals;

- an inability to raise or sustain prices for products or services;

- an inability to maintain appropriate relations with unions and

employees in certain locations in order to avoid business disruptions;

- any change in any agreements with product suppliers to PolyOne

Distribution that prohibits PolyOne from continuing to distribute a

supplier's products to customers;

- the ability to successfully integrate GLS; and

- other factors affecting our business beyond our control, including,

without limitation, changes in the general economy, changes in interest

rates and changes in the rate of inflation.

We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements.

We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Securities and Exchange Commission. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider any list to be a complete set of all potential risks or uncertainties. (Ref. #10208)


'/>"/>
SOURCE PolyOne Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: